Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Movano ( (MOVE) ) is now available.
On August 28, 2025, Movano Health announced that it received an extension from the Nasdaq Hearings Panel to regain compliance with Nasdaq’s listing rules. The company must file its overdue quarterly reports by September 30, 2025, and maintain a minimum $1.00 per share bid price by October 30, 2025. The extension follows a hearing on August 19, 2025, where Movano presented its compliance plan, including a reverse stock split proposal to be voted on at the upcoming shareholders meeting. This extension is crucial for Movano to maintain its Nasdaq listing, impacting its market presence and stakeholder confidence.
The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.
Spark’s Take on MOVE Stock
According to Spark, TipRanks’ AI Analyst, MOVE is a Underperform.
Movano’s stock faces significant challenges primarily due to its weak financial performance, marked by negative profitability and cash flow issues. The technical analysis indicates a bearish trend with poor market momentum, and valuation metrics are unfavorably low. Overall, the stock needs substantial improvement in operational efficiency and market perception to enhance its attractiveness.
To see Spark’s full report on MOVE stock, click here.
More about Movano
Movano Inc., operating as Movano Health, is a company founded in 2018 that specializes in developing healthcare solutions through wearable technology. Their primary product, the Evie Ring, is designed to provide medical-grade data in a modern and flexible form factor, aiming to deliver personalized health insights to both consumers and enterprises.
Average Trading Volume: 575,283
Technical Sentiment Signal: Sell
Current Market Cap: $4.83M
See more insights into MOVE stock on TipRanks’ Stock Analysis page.